PuSH - Publication Server of Helmholtz Zentrum München

The association of antihypertensive treatment patterns and adverse lipid effects in population-based studies.

J. Clin. Epidemiol. 45, 1423-1430 (1992)
Open Access Green as soon as Postprint is submitted to ZB.
We investigated the relationship between antihypertensive drug treatment of hypertensives and their mean serum lipid concentrations in population based studies in Germany. Data from three surveys (Luebeck Blood Pressure Study (LBS) of 1984, MONICA Augsburg Survey I of 1984/85, MONICA Augsburg Survey II of 1989/90), obtained on random samples of the population aged 25-64 years, were used for cross-sectional analyses. Moreover, prospective analyses were carried out on participants of the MONICA Augsburg cohort study of 1987/88 (3-year-follow-up of the MONICA Survey I). Blood pressure, non-fasting serum total cholesterol and HDL-cholesterol, and body height and weight were measured under strictly standardized conditions. Interview data were available on medical history including medication use, and on smoking and alcohol consumption. In cross-sectional and prospective analyses treated male and female hypertensives in each population had significantly lower crude mean HDL-C concentrations than untreated hypertensives, borderliners, or normotensives. Differences in mean HDL-C between untreated and treated hypertensives were attenuated but still significant after control of confounders and ranged from 1.8 to 6.1 mg/dl (i.e. in relative terms, -3.4 to -12.9%) in men and from 3.6 to 9.4 mg/dl (-5.7 to -14.9%) in women. By contrast, crude and multivariate associations of antihypertensive treatment with non-HDL-C (total minus HDL-C) levels were inconsistent and not significant. The inverse association of drug therapy with HDL-C was confirmed by prospective analyses in the MONICA cohort study supporting a causal relationship. Treatment patterns in a community (prevalence of prescribed drug classes) correlated with the magnitude and significance of HDL-C effects. Despite the diversity of brands and substances used, treated hypertensives consistently had the lowest HDL-C levels of all blood pressure strata in a population. We assume this to indicate permanent, common and rather substantial HDL-C effects of present antihypertensive treatment patterns. Mass treatment of hypertension may suffer sizable reductions in the overall benefit as a consequence of the observed associations. We suggest that from a public health point of view this aspect should be given more attention.
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Keywords Antihypertensive Medication ; Cholesterol ; Epidemiology ; High Density Lipoprotein ; Population-based Study ; Treatment Patterns
ISSN (print) / ISBN 0895-4356
e-ISSN 0895-4356
Quellenangaben Volume: 45, Issue: 12, Pages: 1423-1430 Article Number: , Supplement: ,
Publisher Elsevier
Reviewing status Peer reviewed
Institute(s) Institute of Epidemiology (EPI)